UP!

JNS $14.17

JNS target price
14.17
0
0
Janus Capital Group Inc.
Type
Public company
Traded as NYSE: JNS
Industry Financial
Founded 1969
Founder Tom Bailey
Headquarters Denver, Colorado, United States
Revenue $1,076 million (2015)
AUM $190.9 billion (2016)
Number of employees
1,272 (2016)
Website www.janus.com

Janus Capital Group, Inc. was an American publicly owned investment firm headquartered in Denver, Colorado. The company's asset-management disciplines included growth, core, international, value, mathematical, alternative and fixed-income. These products were sold through advisors and financial intermediaries, to institutional investors and directly to retail investors. Janus Capital Group was created as a result of the January 1, 2003, merger of Janus Capital Corporation into its parent company, Stilwell Financial Inc. Janus Capital Group consists of Janus Capital Management LLC (Janus), INTECH Investment Management LLC (INTECH), and Kapstream Capital Pty Limited (Kapstream), in addition to a range of exchange‐traded products. Additionally, Janus Capital Group owns 80% of Perkins Investment Management (formerly Perkins, Wolf, McDonnell and Company).

Outside the U.S., Janus had offices in Sydney, Paris, Zurich, Frankfurt, Dubai, Taipei, London, Milan, Tokyo, Hong Kong, Melbourne, and Singapore. Janus is in the S&P MidCap 400 Index.

It merged with Henderson Group in May 2017 to create Janus Henderson.

Janus was founded in 1969 by Tom Bailey. A controlling interest was purchased by Kansas City Southern Industries in 1984. Bailey stepped down as president and CEO in June 2002.

The firm was formerly known as Stilwell Financial Incorporated. The company was renamed following the January 2003 merger of Janus Capital Corporation into its parent company, Stilwell Financial.

The Janus Fund opened in 1970 with approximately $500,000,000.35 in assets and 30 investors. Its primary business was U.S. large cap growth equity management.

Further funds were launched in 1985, including the Janus Venture Fund, its first small cap equity fund, and the Janus Twenty Fund, its first concentrated equity fund. At the same time, Janus began managing assets for institutional clients.

In 1991, Janus launched a number of other new types of fund, including its first global equity fund, the Janus Worldwide Fund, its first international equity fund, the Janus Overseas Fund, and its first mid cap equity fund, the Janus Enterprise Fund. It also launched the Janus Aspen Series (JAS), a product line created for investors wanting to invest in Janus through variable insurance contracts or certain qualified retirement plans. Janus also became available through fund supermarkets for both retail shareholders and financial planners.

Myron Scholes, Nobel laureate and Ph.D., joined Janus as chief investment strategist on July 8, 2014 On September 26, 2014, Bill Gross left Pimco to join Janus as manager of the Janus global unconstrained bond strategy. In October 2014, Janus acquired VS Holdings, a company based in Darien, Connecticut, and its VelocityShares business. In July 2015, Janus acquired a majority interest in Kapstream Capital, a fixed income specialist. In February 2016, Janus launched a small cap growth and small cap/mid cap growth ETF, followed in June by four new ETFs around investment themes – long-term care, health and fitness, organic foods and personal care (including health care issues related to obesity). On October 3, 2016, Janus Capital Group Inc and Henderson Group plc announced a recommended merger of equals to create Janus Henderson.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-05-26 Downgrade Wells Fargo Outperform to Market Perform
2016-05-26 Downgrade Wells Fargo & Co. Outperform to Market Perform
2016-05-12 Downgrade Wells Fargo Outperform to Market Perform
2016-04-27 Reiterated Rating Morgan Stanley Sell
2016-04-12 Boost Price Target Sandler O'Neill $13.00 to $15.00
2016-03-13 Lower Price Target Morgan Stanley Underweight $13.00 to $12.00
2016-01-28 Reiterated Rating Jefferies Group Buy
2016-01-27 Lower Price Target Keefe, Bruyette & Woods Market Perform $15.25 to $14.00
2016-01-27 Lower Price Target JPMorgan Chase & Co. $15.00 to $14.00
2016-01-13 Downgrade JPMorgan Chase & Co. Overweight to Neutral $22.00 to $15.00
2016-01-11 Reiterated Rating Keefe, Bruyette & Woods Hold $17.00 to $15.25
2016-01-11 Downgrade Goldman Sachs Buy to Neutral
2016-01-11 Downgrade Goldman Sachs Group Inc. Buy to Neutral
2015-10-23 Reiterated Rating Jefferies Group Buy
2015-10-23 Boost Price Target Keefe, Bruyette & Woods $15.00 to $17.00
2015-10-08 Lower Price Target Credit Suisse $15.00
2015-10-08 Lower Price Target Credit Suisse Group AG $15.00
2015-10-07 Reiterated Rating Jefferies Group Buy $21.00 to $17.00
2015-10-05 Reiterated Rating JPMorgan Chase & Co. Buy
2015-10-01 Reiterated Rating Off Wall Street Sell
2015-09-21 Downgrade Morgan Stanley Equal Weight to Underweight
2015-09-08 Lower Price Target JPMorgan Chase & Co. Overweight $20.50 to $18.00
2015-09-03 Lower Price Target Keefe, Bruyette & Woods Market Perform $19.50 to $15.25
2015-07-15 Reiterated Rating Citigroup Inc. Hold $18.50 to $16.50
2015-07-03 Reiterated Rating JPMorgan Chase & Co. Buy
2015-07-02 Lower Price Target JPMorgan Chase & Co. Overweight $21.50 to $21.00
2015-06-08 Initiated Coverage Goldman Sachs Buy $22.00
2015-06-02 Initiated Coverage Piper Jaffray Overweight $22.00
2015-06-02 Initiated Coverage Piper Jaffray Cos. Overweight $22.00
2015-05-28 Initiated Coverage Wells Fargo & Co. Outperform $20.00 to $22.00
2015-05-28 Initiated Coverage Wells Fargo Outperform $20.00 to $22.00
2015-04-24 Boost Price Target Citigroup Inc. Neutral $17.00 to $18.50
2015-04-02 Boost Price Target JPMorgan Chase & Co. Overweight $19.50 to $20.50
2015-03-23 Boost Price Target Jefferies Group Buy $20.00 to $21.00
2015-03-19 Upgrade Citigroup Inc. Sell to Neutral $14.50 to $17.00
2015-03-17 Lower Price Target JPMorgan Chase & Co. Overweight $20.00 to $19.50
2015-01-23 Boost Price Target Keefe, Bruyette & Woods Market Perform $17.25 to $19.00
2015-01-23 Set Price Target Jefferies Group Buy $18.00 to $20.00
2015-01-23 Boost Price Target Citigroup Inc. Sell $13.50 to $14.50
2015-01-16 Upgrade JPMorgan Chase & Co. Neutral to Overweight $20.00
2015-01-09 Boost Price Target Citigroup Inc. Sell $12.50 to $13.50
2015-01-08 Boost Price Target Keefe, Bruyette & Woods Market Perform $16.50 to $17.25
2015-01-07 Boost Price Target Jefferies Group Buy $17.00 to $18.00
2015-01-07 Upgrade JPMorgan Chase & Co. Underweight to Overweight $16.00 to $20.00
2015-01-06 Upgrade Credit Suisse Underperform to Neutral $17.00 to $19.00
2014-12-09 Boost Price Target Keefe, Bruyette & Woods Market Perform $14.00 to $16.50
2014-10-27 Reiterated Rating Keefe, Bruyette & Woods Market Perform $17.00 to $14.00
2014-10-24 Reiterated Rating Credit Suisse Underperform $17.25 to $16.50
2014-10-23 Downgrade Citigroup Inc. Neutral to Sell
2014-10-14 Reiterated Rating Bank of America Neutral $15.00 to $14.50
2014-10-14 Reiterated Rating Bank of America Corp. Neutral $15.00 to $14.50
2014-10-01 Reiterated Rating JPMorgan Chase & Co. Underweight $13.00 to $14.00
2014-10-01 Upgrade Jefferies Group Hold to Buy $12.50 to $17.00
2014-09-29 Downgrade Makor Capital Buy to Hold
2014-09-29 Reiterated Rating Keefe, Bruyette & Woods Market Perform $13.00 to $17.00
2014-09-26 Upgrade Citigroup Inc. Sell to Neutral $10.00 to $14.50
2014-09-26 Reiterated Rating Credit Suisse Underperform $14.00 to $17.25
2014-09-18 Initiated Coverage Wall Street Strategies Strong Sell to Sell
2014-07-24 Reiterated Rating JPMorgan Chase & Co. Underweight $10.50 to $11.00
2014-07-14 Boost Price Target Keefe, Bruyette & Woods $12.75 to $13.00
2014-07-01 Boost Price Target JPMorgan Chase & Co. Underweight $10.00 to $10.50
2014-04-23 Reiterated Rating Citigroup Inc. Sell $9.00
2014-04-23 Boost Price Target Keefe, Bruyette & Woods $11.25 to $12.75
2014-04-15 Boost Price Target JPMorgan Chase & Co. Underweight $9.50 to $10.00
2014-03-21 Lower Price Target JPMorgan Chase & Co. $10.50 to $9.50
2014-03-04 Boost Price Target Credit Suisse $10.50 to $11.25
2014-01-28 Lower Price Target Barclays Underweight $11.00 to $9.00
2014-01-14 Boost Price Target JPMorgan Chase & Co. Underweight $9.50 to $11.00
2014-01-10 Upgrade Goldman Sachs Sell to Neutral
2014-01-10 Reiterated Rating Keefe, Bruyette & Woods Market Perform $9.75 to $11.25
2013-10-25 Boost Price Target Keefe, Bruyette & Woods Market Perform $9.25 to $9.75
2013-10-25 Boost Price Target JPMorgan Chase & Co. Underweight $9.00 to $9.50
2013-10-08 Reiterated Rating Barclays Sell $7.00
2013-10-08 Boost Price Target JPMorgan Chase & Co. Underweight $8.00 to $9.00
2009-08-04 Upgrade Stifel Nicolaus Hold to Buy $16.50
2009-06-08 Reiterated Barclays Capital Underweight $5 to $10
2016-05-26 Downgrade Wells Fargo Outperform to Market Perform
2016-05-26 Downgrade Wells Fargo & Co. Outperform to Market Perform
2016-05-12 Downgrade Wells Fargo Outperform to Market Perform
2016-04-27 Reiterated Rating Morgan Stanley Sell
2016-04-12 Boost Price Target Sandler O'Neill $13.00 to $15.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
DAI ICHI LIFE INSURANCE CO., LTD. 19.35%  (36382545) JNS /
WEIL RICHARD M Chief Executive Officer 1.04%  (1953724) JNS /
Chang Enrique President, Head of Investments 0.39%  (733862) JNS /
KOEPFGEN BRUCE L EVP and CFO 0.21%  (395963) JNS /
BEERY ROBIN C EVP, Head of U.S. Distribution 0.15%  (287602) JNS / UMBF /
Cheh Augustus Head of International 0.10%  (193251) JNS /
McPeek Jennifer J SVP, Chief Financial Officer 0.08%  (157111) JNS /
COX G ANDREW 0.05%  (99399) JNS /
GATZEK DEBORAH R 0.05%  (98135) JNS /
BALSER PAUL F 0.05%  (91485) JNS /
Kochard Lawrence E 0.04%  (75548) JNS /
Batejan George S EVP, Head of IT and Operations 0.04%  (74091) JNS /
FREDERICKS J RICHARD 0.04%  (73892) CADE / JNS /
Hughes Brennan A. VP, Principal Acctng. Officer 0.02%  (34748) JNS /
Armour Timothy K 0.02%  (31121) JNS /
SCHAFER GLENN S 0.02%  (30130) JNS / SKH /
FLOOD EUGENE JR 0.01%  (27396) JNS /
Diermeier Jeffrey J 0.01%  (15959) JNS /
Williamson Billie I. 0.01%  (13252) CSRA / JNS / PNR / XL / XLS /